Filter posts

Is the Polio Vaccine an Anti-Patent Success Story?

By Hans Sauer, Deputy General Counsel for Intellectual Property, Biotechnology Industry Organization Question from a Reader: …

Managing in a Cost-Constrained Environment

By Jill E. Sackman, D.V.M., Ph.D., Senior Consultant, and Matt Levy, J.D., Business Analyst, at …

Let's Get PDUFA V Approved, Fast

By Marc Boutin, JD, Executive Vice President and Chief Operating Officer, National Health Council At …

Biopharma Industry Enthusiastic About 2012

By Eric S. Langer, president and managing partner, BioPlan Associates, Inc. 2012 Annual Study shows budgets, …

"America Speaks" Poll Shows Health Research is Key to Economic Recovery

By Mary Woolley, President of Research!America Research!America’s 12th edition of America Speaks, an annual summary …

HIV/AIDS and Biotechnology

By David Welch, President/Senior Producer at M2 MultiMedia When the HIV/AIDS epidemic became widely known in …

IBM's Watson: From Jeopardy! to Drug Research

Bits of technology from I.B.M.’s Watson are beginning to be used in actual products available …

AAAS Trains Student Scientists in the Art of Science Communication

Rahman A. Culver, project director, American Association for the Advancement of Science From grant writing …

Biomedical Innovation: How the U.S. Can Stay Number One

By Ross DeVol, chief research officer of the Milken Institute “The first step in winning …

Diabetes and Biotechnology: A Shared History…A Great Future

By David Welch, President/Senior Producer at M2 MultiMedia One of my closest childhood friends suffered from …